These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19343126)

  • 1. The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Ramjane K; Han L; Jin C
    Exp Clin Cardiol; 2008; 13(3):121-8. PubMed ID: 19343126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Su Q; Nyi TS; Li L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009503. PubMed ID: 25985145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
    Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
    Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Aung Naing K; Li L; Su Q; Wu T
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of verapamil on the restoration of myocardial perfusion and functional recovery in patients with angiographic no-reflow after primary percutaneous coronary intervention.
    Umemura S; Nakamura S; Sugiura T; Tsuka Y; Fujitaka K; Yoshida S; Baden M; Iwasaka T
    Nucl Med Commun; 2006 Mar; 27(3):247-54. PubMed ID: 16479244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study.
    Jafari Afshar E; Samimisedeh P; Tayebi A; Shafiabadi Hassani N; Rastad H; Yazdani S
    Ther Adv Cardiovasc Dis; 2023; 17():17539447231154654. PubMed ID: 36852839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Quisi A; Alıcı G
    J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction.
    Zhou SS; Tian F; Chen YD; Wang J; Sun ZJ; Guo J; Jin QH
    J Geriatr Cardiol; 2015 Mar; 12(2):135-42. PubMed ID: 25870616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ
    Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.
    Yip HK; Chen MC; Chang HW; Hang CL; Hsieh YK; Fang CY; Wu CJ
    Chest; 2002 Oct; 122(4):1322-32. PubMed ID: 12377860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of no-reflow phenomenon in patients with acute ST-elevation myocardial infarction].
    Krinochkin DV; Bessonov IS; Iaroslavskaia EI; Kuznetsov VA
    Angiol Sosud Khir; 2021; 27(1):39-47. PubMed ID: 33825727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction.
    Li J; Wu L; Tian X; Zhang J; Shi Y
    PLoS One; 2015; 10(6):e0119223. PubMed ID: 26035818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates of the "No-Reflow" or "Slow-Flow" Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention.
    Alidoosti M; Lotfi R; Lotfi-Tokaldany M; Nematipour E; Salarifar M; Poorhosseini H; Jalali A
    J Tehran Heart Cent; 2018 Jul; 13(3):108-114. PubMed ID: 30745923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.